The feasibility of proteomics sequencing based immune-related prognostic signature for predicting clinical outcomes of bladder cancer patients

The feasibility of proteomics sequencing based immune-related prognostic signature for predicting clinical outcomes of bladder cancer patients

Abstract Background Bladder cancer (BCa) shows its potential immunogenity in current immune-checkpoint inhibitor related immunotherapies. However, its therapeutic effects are improvable and could be affected by tumor immune microenvironment. Hence it is interesting to find some more prognostic indic...

Full description

Bibliographic Details
Main Authors: Liren Jiang, Siteng Chen, Qi Pan, Jun Zheng, Jin He, Juanjuan Sun, Yaqin Han, Jiji Yang, Ning Zhang, Guohui Fu, Feng Gao
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Cancer
Subjects:
Immune-related
Prognostic signature
Bladder cancer
PD-1
PD-L1
Online Access:https://doi.org/10.1186/s12885-022-09783-y

Internet

https://doi.org/10.1186/s12885-022-09783-y

Similar Items